Home » Topics » Regulatory » Patents

Patents
RSS

IRL patents cortical cathecolaminergic neurotransmission modulators

Dec. 16, 2016

Chong Kun Dang Holdings divulges new histone deacetylase inhibitors

Dec. 15, 2016

Principia Biopharma patents new FGFR inhibitors

Dec. 15, 2016

Merck & Co. discovers soluble guanylate cyclase activators

Dec. 15, 2016

Harvard and Evotec divulge novel bacterial glycosyl transferase inhibitors

Dec. 15, 2016

TSRI, Icahn School of Medicine and UPenn patent nAChR modulators

Dec. 15, 2016

Shanghai Institute Materia Medica develops tyrosine kinase inhibitors

Dec. 15, 2016

Chinese scientists patent FGFR inhibitors

Dec. 14, 2016

Idenix Pharmaceuticals and Southern Research Institute disclose nucleoside derivatives

Dec. 14, 2016

Novogen presents TMP3 inhibitors

Dec. 14, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest
BioWorld
A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
Pleased to own ya, Kelonia: Lilly’s $7B CAR T deal
BioWorld
The already-thriving CAR T space took another big stride forward as Eli Lilly and Co. disclosed its plan to acquire Boston-based Kelonia Therapeutics Inc. for as...